I can't post file. But here is content in File. It is Fidelity.
COMPANY OVERVIEW Forecasted Upper Limit 5.26$ Best Estimate 2.63$ Forecasted Lower Limit 1.32$ Last Price 2.35$
Ativo Research’s Investment Conclusion
Ativo Research projects as of this date that RAS will OUTPERFORM the market averages over the next 6 to 12 months leading to our decision of a BUY. Our decision is based on (1) valuation, which compares the firm’s intrinsic value against the price of its stock, (2) intermediate and long-term price momentum, (3) other measures of fundamental trend and (4) qualitative analysis.
2 days after the Q-earnings a lot of people have resonded here. I think 50% positive, 50% negative. Imo also research companies are very uncertain about the company.
It looks like this company has big chances according market value to book value, some very optimistic investor on Seeking Alpha, but it looks like most of the real analist and people behind the doors/know the RAS-management etc. have no confidence in the board of this company.
That is a pity for us the investors.
Maybe in the short-term future the best advice for this stock is an HOLD.
I wait a couple of days to see what price will do.
If you analyze 2years price-history of RAS the pattern is BULLISH in other words: the company fundamentals look to improve but in a very uncertain way (which result in the big volatility of this stock).